Pacific Biosciences Of California | PACB - Selling And Administration Expenses


Pacific Biosciences Of California reported $37.24M in Selling and Administration Expenses for its fiscal quarter ending in December of 2025.





Selling And Administration Expenses Change Date
Agilent USD 475M 10M Jun/2026
Bruker USD 238.9M 3.2M Jun/2026
Danaher USD 2.07B 212M Jun/2026
General Electric Aerospace USD 1.13B 47M Jun/2026
Illumina USD 273M 1000K Jun/2026
Myriad Genetics USD 122.3M 6.7M Dec/2025
Pacific Biosciences Of California USD 37.24M 25.68M Dec/2025
Quidel USD 189.7M 9.6M Jun/2026
Revvity USD 278.58M 24.69M Jun/2026
Roche Holding CHF 6.37B 908M Jun/2026
Standard Biotools USD 18.61M 2.94M Mar/2026
Thermo Fisher Scientific USD 1.91B 111M Jun/2026
Waters USD 405M 11M Jun/2026